Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2005)
Potential role of CB 2 receptors in cannabis smokers with chronic hepatitis C
B. Mackness, R. Quarck, W. Verreth, M. Mackness, P. Holvoet (2006)
Human Paraoxonase-1 Overexpression Inhibits Atherosclerosis in a Mouse Model of Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 26
J. Trebicka, I. Rácz, S. Siegmund, E. Cara, M. Granzow, R. Schierwagen, S. Klein, A. Wojtalla, M. Hennenberg, S. Huss, H. Fischer, J. Heller, A. Zimmer, T. Sauerbruch (2011)
Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor‐deficient mice and decreased in CB1 receptor knockoutsLiver International, 31
E. Chieli, G. Malvaldi (1984)
Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide.Toxicology, 31 1
Richard White, W. Ho, F. Bottrill, W. Ford, C. Hiley (2001)
Mechanisms of anandamide‐induced vasorelaxation in rat isolated coronary arteriesBritish Journal of Pharmacology, 134
H. Moshage, B. Kok, J. Huizenga, Peter Jansen (1995)
Nitrite and nitrate determinations in plasma: a critical evaluation.Clinical chemistry, 41 6 Pt 1
JC Turner, PG Mahlberg (1984)
Chemical Pharmacol Ther Agents
M. Huestis (2002)
Cannabis (Marijuana) - Effects on Human Performance and Behavior.Forensic science review, 14 1-2
RVA Drury, EA Walligton (1980)
Carltons histological techniques
Shuyun Wang, Hua-mei Tang, Guo-qing Chen, Junming Xu, L. Zhong, Zhaowen Wang, Gui-long Deng, Tonghai Xing, Lungen Lu, Zhi-Hai Peng (2012)
Effect of Ursodeoxycholic Acid Administration after Liver Transplantation on Serum Liver Tests and Biliary Complications: A Randomized Clinical TrialDigestion, 86
A. Louvet, F. Teixeira-Clerc, M. Chobert, V. Deveaux, C. Pavoine, A. Zimmer, F. Pecker, A. Mallat, S. Lotersztajn (2011)
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in miceHepatology, 54
D. Vara, M. Salazar, N. Olea‐Herrero, M. Guzmán, G. Velasco, I. Díaz-Laviada (2011)
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagyCell Death and Differentiation, 18
B. Horváth, Lital Magid, P. Mukhopadhyay, S. Batkai, M. Rajesh, Ogyi Park, Galin Tanchian, Rachel Gao, Catherine Goodfellow, M. Glass, R. Mechoulam, P. Pacher (2012)
A new cannabinoid CB2 receptor agonist HU‐910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injuryBritish Journal of Pharmacology, 165
N. Solowij, R. Stephens, R. Roffman, T. Babor, R. Kadden, Michael Miller, K. Christiansen, B. McRee, J. Vendetti (2002)
Cognitive functioning of long-term heavy cannabis users seeking treatment.JAMA, 287 9
(2002)
Chemical constituents of cannabis
(2002)
Chemical constituents of cannabis. In: Grotenherm en F, Russo E (eds) Cannabis and Cannabinoids. Pharmacology, Toxicology and Therapeutic Potential
A. Floreani, R. Lazzari, V. Macchi, A. Porzionato, A. Variola, D. Colavito, A. Leon, M. Guido, V. Baldo, R. Caro, N. Bergasa (2009)
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosisJournal of Gastroenterology, 45
C. Furlong, Stephanie Suzuki, R. Stevens, J. Marsillach, R. Richter, G. Jarvik, H. Checkoway, A. Samii, L. Costa, L. Costa, A. Griffith, John Roberts, D. Yearout, C. Zabetian (2010)
Human PON1, a biomarker of risk of disease and exposure.Chemico-biological interactions, 187 1-3
C. Reinarman, H. Nunberg, Fran Lanthier, T. Heddleston (2011)
Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment ClinicsJournal of Psychoactive Drugs, 43
P. Hoi, C. Hiley (2006)
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptorBritish Journal of Pharmacology, 147
J. Gutteridge (1995)
Lipid peroxidation and antioxidants as biomarkers of tissue damage.Clinical chemistry, 41 12 Pt 2
M. Huestis (2002)
Cannabis ( Marijuana ) — Effects on Human Behavior and Performance
P. Caraceni, A. Pertosa, F. Giannone, M. Domenicali, I. Grattagliano, A. Principe, C. Mastroleo, Maria‐Giulia Perrelli, J. Cutrin, F. Trevisani, T. Croci, M. Bernardi (2009)
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia–reperfusion injury complicated by endotoxaemiaGut, 58
Ronald Ellis, Will Toperoff, F. Vaida, G. Brande, J. Gonzales, B. Gouaux, Heather Bentley, J Atkinson (2009)
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical TrialNeuropsychopharmacology, 34
Tadashi. Sasaki, S. Eguchi*, T. Toru (1971)
Stereochemistry of the π-route to 2,4-disubstituted adamantanesTetrahedron Letters, 12
Tony Jourdan, L. Demizieux, J. Gresti, Louiza Djaouti, L. Gaba, B. Vergès, P. Degrace (2012)
Antagonism of peripheral hepatic cannabinoid receptor‐1 improves liver lipid metabolism in mice: Evidence from cultured explantsHepatology, 55
I. Túnez, M. Muñoz, M. Villavicencio, F. Medina, Estíbaliz Prado, I. Espejo, M. Barcos, M. Salcedo, M. Feijóo, P. Montilla (2005)
Hepato- and neurotoxicity induced by thioacetamide: protective effects of melatonin and dimethylsulfoxide.Pharmacological research, 52 3
J. Muñoz-Luque, J. Ros, G. Fernández-Varo, S. Tugues, M. Morales-Ruiz, C. Alvarez, S. Friedman, V. Arroyo, W. Jiménez (2008)
Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic RatsJournal of Pharmacology and Experimental Therapeutics, 324
Wei Wang, Nazzareno Ballatori (1998)
Endogenous glutathione conjugates: occurrence and biological functions.Pharmacological reviews, 50 3
R. Pertwee, R. Ross (2002)
Cannabinoid receptors and their ligands.Prostaglandins, leukotrienes, and essential fatty acids, 66 2-3
Maribel Lim, L. Devi, R. Rozenfeld (2011)
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosisCell Death & Disease, 2
C. Furlong (2008)
Paraoxonases: An Historical Perspective
F. Sun, S. Hayami, Y. Ogiri, S. Haruna, K. Tanaka, Y. Yamada, S. Tokumaru, S. Kojo (2000)
Evaluation of oxidative stress based on lipid hydroperoxide, vitamin C and vitamin E during apoptosis and necrosis caused by thioacetamide in rat liver.Biochimica et biophysica acta, 1500 2
J. Camps, J. Marsillach, J. Joven (2009)
Measurement of serum paraoxonase-1 activity in the evaluation of liver function.World journal of gastroenterology, 15 16
Robert Schwabe, Soeren Siegmund (2005)
Potential role of CB2 receptors in Cannabis smokers with chronic hepatitis CHepatology, 42
P. Borini, R. Guimarães, S. Borini (2004)
Possible hepatotoxicity of chronic marijuana usage.Sao Paulo medical journal = Revista paulista de medicina, 122 3
A. Watson, J. Berliner, S. Hama, B. Du, K. Faull, A. Fogelman, M. Navab (1995)
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.The Journal of clinical investigation, 96 6
S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey‐White, A. Jafri, G. Haskó, J. Huffman, B. Gao, G. Kunos, P. Pacher (2007)
Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injuryThe FASEB Journal, 21
N. Sanz, C. Díez‐Fernández, D. Andrés, M. Cascales (2002)
Hepatotoxicity and aging: endogenous antioxidant systems in hepatocytes from 2-, 6-, 12-, 18- and 30-month-old rats following a necrogenic dose of thioacetamide.Biochimica et biophysica acta, 1587 1
M. Ware, Tongtong Wang, S. Shapiro, A. Robinson, T. Ducruet, T. Huynh, A. Gamsa, G. Bennett, J. Collet (2010)
Smoked cannabis for chronic neuropathic pain: a randomized controlled trialCanadian Medical Association Journal, 182
K. Higashino, Y. Takahashi, Y. Yamamura (1972)
Release of phenyl acetate esterase from liver microsomes by carbon tetrachloride.Clinica chimica acta; international journal of clinical chemistry, 41
M. Başkol, G. Baskol, K. Deniz, O. Ozbakır, M. Yücesoy (2005)
A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 16 3
B. Mackness, M. Mackness, M. Aviram, G. Paragh (2008)
Book - The Paraoxonases: Their role in disease development and xenobiotic metabolism
H. Wehr, M. Bednarska-Makaruk, A. Graban, W. Lipczyńska-Łojkowska, M. Rodo, A. Bochyńska, D. Ryglewicz (2009)
Paraoxonase activity and dementiaJournal of the Neurological Sciences, 283
L. Crowley (1967)
The Reitman-Frankel colorimetric transaminase procedure in suspected myocardial infarction.Clinical chemistry, 13 6
J. Ros, J. Clària, J. To-Figueras, A. Planagumà, P. Cejudo-Martı́n, G. Fernández-Varo, Raúl Martı́n-Ruiz, V. Arroyo, F. Rivera, J. Rodés, W. Jiménez (2002)
Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.Gastroenterology, 122 1
(2008)
A (2008) Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis
D. Sylvestre, Barry Clements, Yvonne Malibu (2006)
Cannabis use improves retention and virological outcomes in patients treated for hepatitis CEuropean Journal of Gastroenterology & Hepatology, 18
Ethan Russo, J. McPartland (2003)
Cannabis is more than simply delta(9)-tetrahydrocannabinol.Psychopharmacology, 165 4
M. Ruiz-Larrea, A. Leal, M. Liza, M. Lacort, H. Groot (1994)
Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomesSteroids, 59
MA ElShohly (2002)
Cannabis and Cannabinoids. Pharmacology, Toxicology and Therapeutic Potential
B. Mackness, M. Mackness, M. Aviram, G. Paragh (2008)
Comprar The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism | Mackness, Bharti | 9781402065606 | Springer
R. Saller, R. Meier, R. Brignoli (2012)
The Use of Silymarin in the Treatment of Liver DiseasesDrugs, 61
N. Ferré, J. Camps, E. Prats, E. Vilella, A. Paul, L. Figuera, J. Joven (2002)
Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.Clinical chemistry, 48 2
E. Toson (2011)
Impact of marijuana smoking on liver and sex hormones: Correlation with oxidative stress
M. Ware, M. Fitzcharles, L. Joseph, Y. Shir (2010)
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled TrialAnesthesia & Analgesia, 110
K. Venderová, E. Růžička, V. Voříšek, P. Višňovský (2004)
Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptomsMovement Disorders, 19
S. Primo-Parmo, R. Sorenson, J. Teiber, B. Du (1996)
The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.Genomics, 33 3
A. Singal, Sarat Jampana, S. Weinman (2011)
Antioxidants as therapeutic agents for liver diseaseLiver International, 31
O. Sagredo, M. Pazos, V. Satta, J. Ramos, R. Pertwee, J. Fernández-Ruiz (2011)
Neuroprotective effects of phytocannabinoid‐based medicines in experimental models of Huntington's diseaseJournal of Neuroscience Research, 89
C. Hézode, E. Zafrani, F. Roudot-thoraval, C. Costentin, A. Hessami, M. Bouvier-Alias, F. Medkour, Jean‐Michel Pawlostky, S. Lotersztajn, A. Mallat (2008)
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.Gastroenterology, 134 2
G. Poli (2000)
Pathogenesis of liver fibrosis: role of oxidative stress.Molecular aspects of medicine, 21 3
R. Mechoulam, Y. Gaoni (1967)
The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish.Tetrahedron Letters, 8
J. Medina, R. Moreno-otero (2012)
Pathophysiological Basis for Antioxidant Therapy in Chronic Liver DiseaseDrugs, 65
S. Uskoković-Marković, M. Milenkovic, A. Topić, J. Kotur-Stevuljević, A. Stefanović, J. Antić-Stanković (2007)
Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in wistar rats.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 10 3
R. Pertwee (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.British journal of pharmacology, 153 2
J. Turner, P. Mahlberg (1984)
SEPARATION OF ACID AND NEUTRAL CANNABINOIDS IN CANNABIS SATIVA L. USING HPLC
(2005)
A (2005) Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis
Z. Járai, G. Kunos (2002)
[Cardiovascular effects of cannabinoids].Orvosi hetilap, 143 26
M. Harvey, J. Sellman, R. Porter, C. Frampton (2007)
The relationship between non-acute adolescent cannabis use and cognition.Drug and alcohol review, 26 3
A. Belfield, D. Goldberg (1971)
Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine.Enzyme, 12 5
(1980)
Carltons histological techniques, 5th edn
J. Lee, K. Shin, Michael Lee, E. Kim, Sang‐Seop Han, M. Han, H. Ha, T. Jeong, W. Koh (2003)
Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression.Toxicology letters, 136 3
O. Abdel-Salam, Saffa Metwaly, A. Sleem, F. Morsy, H. Sharaf (2013)
Cannabis sativa exacerbates hepatic injury caused by acetaminophen or carbon tetrachloride in ratsComparative Clinical Pathology, 22
J. Kotur-Stevuljević, S. Spasić, Z. Jelić-Ivanović, V. Spasojević-Kalimanovska, A. Stefanović, A. Vujovic, L. Memon, D. Kalimanovska‐Oštrić (2008)
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.Clinical biochemistry, 41 13
G. Ellman (1959)
Tissue sulfhydryl groups.Archives of biochemistry and biophysics, 82 1
K. Flora, M. Hahn, H. Rosen, K. Benner (1998)
Milk Thistle (Silybum marianum) for the Therapy of Liver DiseaseAmerican Journal of Gastroenterology, 93
AD Watson, JA Berliner, SY Hama, BN Du, KF Faull, AM Fogelman, M Navab (1995)
Protective effect of high density lipoprotein associated paraoxonaseInhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest, 96
P. Zygmunt, J. Petersson, D. Andersson, H. Chuang, M. Sørgård, V. Marzo, D. Julius, E. Högestätt (1999)
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamideNature, 400
A. Çakmak, D. Zeyrek, A. Ataş, Ş. Selek, O. Erel (2009)
Oxidative status and paraoxonase activity in children with asthma.Clinical and investigative medicine. Medecine clinique et experimentale, 32 5
C. Hézode, F. Roudot-thoraval, S. Nguyen, P. Grenard, B. Julien, E. Zafrani, Jean‐Michel Pawlostky, D. Dhumeaux, S. Lotersztajn, A. Mallat (2005)
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis CHepatology, 42
J. Sastre-Garriga, C. Vila, S. Clissold, X. Montalban (2011)
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosisExpert Review of Neurotherapeutics, 11
Julie Ishida, M. Peters, Chengshi Jin, K. Louie, V. Tan, P. Bacchetti, N. Terrault (2008)
Influence of cannabis use on severity of hepatitis C disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 6 1
R. Pertwee (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 153
Ying-Ying Yang, Han‐Chieh Lin, Yi‐Tsau Huang, Tzung-Yan Lee, M. Hou, Ying‐Wen Wang, F. Lee, Shou-Dong Lee (2007)
Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis.Clinical science, 112 10
B. Julien, P. Grenard, F. Teixeira-Clerc, J. Nhieu, Liying Li, M. Karsak, A. Zimmer, A. Mallat, S. Lotersztajn (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.Gastroenterology, 128 3
F. Teixeira-Clerc, B. Julien, P. Grenard, J. Nhieu, V. Deveaux, Liying Li, V. Serrière-Lanneau, C. Ledent, A. Mallat, S. Lotersztajn (2006)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosisNature Medicine, 12
Cannabis sativa preparations are the most widely used illicit drugs worldwide. The present study aimed to examine the effect of C. sativa extract on liver injury caused by thioacetamide in the rat. Thioacetamide was administered at 50 mg/kg twice weekly via subcutaneous route (s.c.) for 2 weeks. Starting from the first dose of thioacetamide, rats were treated with either C. sativa at doses of 10 or 20 mg/kg (expressed as Δ9-tetrahydrocannabinol), silymarin (25 mg/kg) or saline, once daily s.c., for 2 weeks. Reduced glutathione (GSH), lipid peroxidation (malondialdehyde; MDA) and nitric oxide concentrations were measured in the liver and brain. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), paraoxonase 1 activities (PON1) and total proteins were determined in serum. Hepatic injury was also determined via histological examination of liver sections. The administration of only cannabis to saline-treated rats had no significant effect on serum liver enzymes or on the hepatic levels of GSH, MDA or nitric oxide. Serum PON1 decreased by 21.9 % by 20 mg/kg cannabis. The level of MDA and nitric oxide in brain decreased by only cannabis administration. In thioacetamide-treated rats, the administration of cannabis extract (10 or 20 mg/kg) did not alter the level of MDA, GSH or nitric oxide in hepatic tissue. Serum ALT or AST were not significantly altered, but ALP increased significantly by 38.9 % after treatment with 20 mg/kg cannabis. Serum PON1 activity which showed marked decrease in thioacetamide-treated rats, increased by 18.9 and 151 % after C. sativa treatment. Serum proteins increased after the administration of cannabis (by 20.4 and 21.3 %, respectively). In brain tissue, both MDA and nitric oxide were significantly decreased by cannabis. Meanwhile, treatment with silymarin resulted in significant decrease in MDA and increased GSH in the liver tissue. Serum AST, ALT and ALP were significantly decreased, while PON1 activity was increased after silymarin. In brain, MDA decreased by 27.9 % after silymarin. Cannabis alone caused histological liver damage and fibrosis and neuronal degeneration. The liver tissue damage and brain degeneration caused by thioacetamide were enhanced by cannabis but almost prevented by silymarin treatment. It is concluded that the administration of C. sativa exacerbates the thioacetamide-induced liver and brain injury.
Comparative Clinical Pathology – Springer Journals
Published: Nov 8, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.